These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 24993769

  • 1. Protocol for a randomised controlled trial of VAsopressin versus Noradrenaline as Initial therapy in Septic sHock (VANISH).
    Gordon AC, Mason AJ, Perkins GD, Ashby D, Brett SJ.
    BMJ Open; 2014 Jul 03; 4(7):e005866. PubMed ID: 24993769
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients.
    Russell JA, Vincent JL, Kjølbye AL, Olsson H, Blemings A, Spapen H, Carl P, Laterre PF, Grundemar L.
    Crit Care; 2017 Aug 15; 21(1):213. PubMed ID: 28807037
    [Abstract] [Full Text] [Related]

  • 5. The effects of vasopressin on acute kidney injury in septic shock.
    Gordon AC, Russell JA, Walley KR, Singer J, Ayers D, Storms MM, Holmes CL, Hébert PC, Cooper DJ, Mehta S, Granton JT, Cook DJ, Presneill JJ.
    Intensive Care Med; 2010 Jan 15; 36(1):83-91. PubMed ID: 19841897
    [Abstract] [Full Text] [Related]

  • 6. Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study.
    Morelli A, Ertmer C, Rehberg S, Lange M, Orecchioni A, Cecchini V, Bachetoni A, D'Alessandro M, Van Aken H, Pietropaoli P, Westphal M.
    Crit Care; 2009 Jan 15; 13(4):R130. PubMed ID: 19664253
    [Abstract] [Full Text] [Related]

  • 7. Beneficial effects of short-term vasopressin infusion during severe septic shock.
    Patel BM, Chittock DR, Russell JA, Walley KR.
    Anesthesiology; 2002 Mar 15; 96(3):576-82. PubMed ID: 11873030
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The Septic Shock 3.0 Definition and Trials: A Vasopressin and Septic Shock Trial Experience.
    Russell JA, Lee T, Singer J, Boyd JH, Walley KR, Vasopressin and Septic Shock Trial (VASST) Group.
    Crit Care Med; 2017 Jun 15; 45(6):940-948. PubMed ID: 28333757
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of continuous vasopressin infusion in patients with septic shock.
    Obritsch MD, Jung R, Fish DN, MacLaren R.
    Ann Pharmacother; 2004 Jun 15; 38(7-8):1117-22. PubMed ID: 15178740
    [Abstract] [Full Text] [Related]

  • 14. Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock.
    Hall LG, Oyen LJ, Taner CB, Cullinane DC, Baird TK, Cha SS, Sawyer MD.
    Pharmacotherapy; 2004 Aug 15; 24(8):1002-12. PubMed ID: 15338849
    [Abstract] [Full Text] [Related]

  • 15. The cardiopulmonary effects of vasopressin compared with norepinephrine in septic shock.
    Gordon AC, Wang N, Walley KR, Ashby D, Russell JA.
    Chest; 2012 Sep 15; 142(3):593-605. PubMed ID: 22518026
    [Abstract] [Full Text] [Related]

  • 16. Low-dose vasopressin in the treatment of vasodilatory septic shock.
    Malay MB, Ashton RC, Landry DW, Townsend RN.
    J Trauma; 1999 Oct 15; 47(4):699-703; discussion 703-5. PubMed ID: 10528604
    [Abstract] [Full Text] [Related]

  • 17. External Corroboration That Corticosteroids May Be Harmful to Septic Shock Endotype A Patients.
    Wong HR, Hart KW, Lindsell CJ, Sweeney TE.
    Crit Care Med; 2021 Jan 01; 49(1):e98-e101. PubMed ID: 33156120
    [Abstract] [Full Text] [Related]

  • 18. Mortality, Morbidity, and Costs After Implementation of a Vasopressin Guideline in Medical Intensive Care Patients With Septic Shock: An Interrupted Time Series Analysis.
    Bauer SR, Sacha GL, Reddy AJ.
    Ann Pharmacother; 2020 Apr 01; 54(4):314-321. PubMed ID: 31679395
    [Abstract] [Full Text] [Related]

  • 19. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock.
    Russell JA, Walley KR, Gordon AC, Cooper DJ, Hébert PC, Singer J, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Dieter Ayers for the Vasopressin and Septic Shock Trial Investigators.
    Crit Care Med; 2009 Mar 01; 37(3):811-8. PubMed ID: 19237882
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.